Source plasma collection in the United States: Toward a more personalized approach-Reference-Cited by-同舟云学术

Source plasma collection in the United States: Toward a more personalized approach

Published:2020-04-20 Issue:6 Volume:95 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Hartmann Jan¹^ORCID,Ragusa Michael J.¹,Popovsky Mark A.¹,Leitman Susan F.²

Affiliation:

1. Haemonetics Corporation Boston MA USA

2. NIH Clinical CenterNational Institutes of Health Bethesda MD USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25817

Reference7 articles.

1. U.S. Food & Drug Administration. Information about immune globulin (human) product shortage. 2018.https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/information-about-immune-globulin-human-product-shortage[21 November 2019].

2. Protein levels and plasmapheresis intensity

3. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA)

4. Food and Drug Administration HHS. Volume Limits ‐ Automated Collection of Source Plasma.https://www.fda.gov/media/70951/download[22 July 2019].

5. GustafsonM.Source Plasma Donor Hemovigilance Activities and Results. 2017.https://www.pptaglobal.org/images/presentations/2017/Gustafson_PlasmaVigilance100817.pdf[22 July 2019].

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large‐scale real‐world data analysis of source plasma collections using a novel technology‐enabled nomogram;Transfusion;2023-10-15

2. Risk factors for T‐cell lymphopenia in frequent platelet donors: The BEST collaborative study;Transfusion;2023-10-11

3. A donor safety evidence literature review of the short‐ and long‐term effects of plasmapheresis;Vox Sanguinis;2023-08-29

4. Timing of hypotensive adverse events in U.S. source plasma donors: Exploratory analysis from the IMPACT trial;Transfusion and Apheresis Science;2022-12

5. Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study;Transfusion Medicine and Hemotherapy;2022